Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye sees a strong Q1’22 report from Stille, where sales in the operating tables segment surprised us positively.</li><li>With the global healthcare sector gradually returning to normal surgical procedures, we see a strong demand for Stille’s products in both segments going forward.</li></ul>

Redeye sees a strong Q1’22 report from Stille, where sales in the operating tables segment surprised us positively.With the global healthcare sector gradually returning to normal surgical procedures, we see a strong demand for Stille’s products in both segments going forward.

Stille Q1’22: Strong Quarter, Despite Supply Chain Challenges